Lipid mediator pathway

Lipid mediator pathway refers to the collective biosynthetic and signaling routes by which bioactive lipid mediators are generated and act within the body. These pathways involve the enzymatic conversion of membrane-derived polyunsaturated fatty acids into a variety of potent signaling molecules—including prostaglandins, leukotrienes, resolvins, protectins, thromboxanes, sphingolipids, and endocannabinoids—which then exert their effects by binding to specific receptors (often G protein-coupled receptors) on target cells[2][3][5]. The biological actions mediated through these pathways are diverse and include regulation of inflammation (both initiation and resolution), immune responses, vascular tone control, pain perception, cell growth/death decisions, metabolic homeostasis, and more[1][3][5]. Dysregulation or imbalance in these pathways is implicated in numerous diseases such as chronic inflammation disorders (e.g., asthma), cardiovascular diseases (e.g., atherosclerosis), cancer progression/metastasis, neurodegeneration (e.g., Alzheimer’s disease), metabolic syndrome/obesity-related complications[2][3][5]. However—"Lipid mediator pathway" is not itself a single molecular target, receptor or enzyme; rather it describes an entire network of biosynthetic enzymes (such as cyclooxygenases [COX], lipoxygenases [LOX], cytochrome P450s) and cognate receptors for individual lipid mediators. Therefore it does not correspond to a canonical drug target but rather encompasses multiple potential targets within its network[2][3]. For structured data extraction or therapeutic targeting purposes you would need to specify an individual molecule within this system—such as "Prostaglandin E2 receptor," "Leukotriene B4 receptor," "Cyclooxygenase 2," etc.—rather than referring generically to the whole pathway. In summary: The term “lipid mediator pathway” refers broadly to interconnected biochemical routes that generate bioactive lipids involved in cell signaling. It is not itself a discrete molecular entity suitable for direct pharmacological targeting but represents an important conceptual framework encompassing many validated drug targets at the level of specific enzymes or receptors within these networks[2][3]. If you require information about any specific enzyme or receptor within this system—for example “Cyclooxygenase 2” or “Leukotriene B4 receptor”—please specify so detailed structured information can be provided.

Other names

Lipid mediator pathwaysBioactive lipid mediator pathwaysLipid signaling pathways